Find a Doctor or Practice Location

Are you a referring physician?
I am searching for a
Reset Form
Robert A. Burger, MD

Robert A. Burger, MD Physician

Director of Clinical Research and Fellowship Program in Gynecologic Oncology Professor of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania

Dr. Burger is employed by Penn Medicine.

About Dr. Robert A. Burger

Recognized by America's Top Doctors, 2014 - 2018

Recognized by Best Doctors in America - 2013 - 2018

Recognized by Philadelphia magazine's annual Top Docs issues 2014 - 2018

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Clinical Specialties


  • Gynecologic Oncology

Programs & Centers:

Board Certification:

  • ObGyn/GynecologicOncology (AMA)
  • Obstetrics and Gynecology, 1997

Clinical Expertise:

  • Cervical Cancer
  • Cervical Dysplasia
  • Cervical Lesions
  • Cervix Biopsy
  • Chemotherapy for Gynecologic Cancers
  • Colposcopy
  • Endometrial Cancer
  • Fallopian Tube Cancer
  • Gynecologic Cancer
  • Gynecologic Cancer Surgery
  • Gynecologic Surgery
  • Gynecology Clinical Trials
  • Hysterectomy (Uterus Surgery)
  • Hysteroscopy
  • Laparoscopic Hysterectomy
  • Laparoscopic Supracervical Hysterectomy
  • Laparoscopic Surgery
  • Laparoscopy
  • Loop Electrosurgical Excision Procedure (LEEP)
  • Minimally Invasive Hysterectomy
  • Ovarian Cancer
  • Robotic Surgery
  • Trophoblastic Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Vulvar Cancer

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Vetrans Choice Program (6/2018 Not Active)

Education and Training

Medical School: New York University School of Medicine
Residency: Hospital of the University of Pennsylvania
Fellowship: UC at Irvine Medical Center


American Association for Cancer Research (AACR), National American College of Obstetricians and Gynecologists, National American College of Surgeons (FACS), fellow, National GOG Foundation, National Gynecologic Oncology Group, National National Cancer Institute (NCI), Investigator, National NRG Oncology, International NRG Oncology, National Ovarian Cancer National Alliance Scientific and Medical Advisory Board, National Society of Gynecologic Oncology (SGO), National Tina's Wish Foundation, National

Hospital Affiliation

Dr. Burger is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.


Selected Publications:

Burger RA, Deng W, Makker V, Collins Y, Gray H Debernardo R, Martin LP, Aghajanian C.: Phase II Evaluation of Dalantercept in the Treatment of Persistent or Recurrent Epithelial Ovarian Cancer: an NRG Oncology/Gynecologic Oncology Group Study Gynecol Oncol In Press : 2018.

Eskander RN, Kauderer J, Tewari KT, Mannel RS, Bristow RE, O'Malley DM, Rubin SC, Glaser GE, Hamilton CA, Fujiwara K, Huh WK, Ueland F, Stephan J-M, Burger RA: Correlation between surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study Gynecol Oncol 149 (3): 525,2018.

Penson RT, Moore KN, Herzog TJ, Burger RA, Freedman LS, Lowenton-Spier N, Harats D, Sher N, Cohen YC, Monk BJ.: Clinical trial in progress: A study of VB-111 combined with paclitaxel vs. paclitaxel for treatment of recurrent platinum-resistant ovarian cancer (OVAL, VB-111-701/GOG-3018). Annual Meeting of the American Society of Clinical Oncology (Oral Presentation), Chicago, IL {Abstract} : 2018.

Burger RA, Enserro D, Tewari KS, Brady MF, Bookman MA, Fleming GF, Huang HQ, Homesley HD, Fowler J, Boente M, Randall LM, Chan JK, Ferris JS, DiSaia PJ, Copeland LJ, Mannel RS, Birrer MJ, Monk BJ: Final overall survival (OS) analysis of an international randomized trial evaluating bevacizumab (BEV) in the primary treatment of advanced ovarian cancer: A NRG oncology/Gynecologic Oncology Group (GOG) study. Annual Meeting of the American Society of Clinical Oncology (Oral Presentation), Chicago, IL (Abstract) : 2018.

Buechel M, Enserro D, Burger RA, Brady MF, Wade K, Alvarez Secord A, Nixon AB, Mirniaharikandehei S, Liu H, Zheng B, Gray G, Tewari KS, O'Malley DM, Mannel RS, Moore KN, Birrer MJ: Correlation of imaging and plasma-based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC): A GOG 218 ancillary data analysis. Annual Meeting of the American Society of Clinical Oncology (Oral Presentation), Chicago, IL (Abstract) : 2018.

Arend RC, Toboni M, Montgomery AM, Burger RA, Olawaiye AB, Monk BJ, Herzog T.: Systemic Treatment of Metastatic/Recurrent Uterine Leiomyosarcoma: A Changing Paradigm. The Oncologist In Press : 2018.

Cory L, Bogner H, Burger R, Chu C, Ko E.: Targeted Educational Interventions Increase Human Papillomavirus Vaccine Acceptability and Knowledge. Oral presentation at: ACOG Annual Clinical and Scientific Meeting; Austin, TX. Abstract : 2018.

Roy AG, Brensinger CM, Lin LL, Giuntoli RL II, Haggerty AF, Latif NA, Burger RA, Morgan MA, Ko EM.: Endometrial cancer survival outcomes differ by geographical region. Poster presentation at the SGO Annual Meeting on Women's Cancer, New Orleans LA (Abstract) : 2018.

Gockley AA, Cronin A, Bookman MA, Burger RA, Cristea M, Griggs JJ, Mantia-Smaldone GM, Meyer LA, O'Malley DM, Wright AA.: Outcomes of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer. Poster presented at the SGO Annual Meeting on Women's Cancer, New Orleans LA. (Abstract) : 2018.

Cory L, Brensinger CM, Haggerty AF, Giuntoli RL II, Latif NA, Burger RA, Morgan MA, Lin LL, Ko EM.: Differences in overall survival associated with type and sequence of adjuvant therapy in stage I uterine carcinosarcoma. Poster presented at the SGO Annual Meeting on Women's Cancer, New Orleans LA. (Abstract) : 2018.

Academic Contact Info

University of Pennsylvania
3400 Civic Center Blvd.
Smilow CTR 8-104

Philadelphia, PA 19104-5156
Phone: (215) 746-4043
Patient appointments: 800-789-7366 (PENN)